Fundraising Fox
Korify Capital
Venture capitalSeries A–Series C · 6 people tracked
Find your way into Korify Capital
Each arrow is one introduction. Sign up to fill in the first one.
Ask Christopher Chuffart to introduce you to Robin Lauber
You →Christopher · together at Prediction Capital →Robin
Ask Jamie Chen to introduce you to Russell Haggar
You →Jamie · together at Prediction Capital →Russell
Ask Sam Okafor to introduce you to Davide Ottolini
You →Sam · together at Infinitas Capital →Davide
- Sean Lauber31 people can intro you
Sign up to find every way you can get introduced to Korify Capital
- Your email: who you already know at Korify Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Korify Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Korify Capital invests in companies advancing longevity and mental health, aiming to help people live long, healthy, and fulfilled lives. The firm backs unique, pioneering approaches led by strong teams that are redefining their sectors. Its investment focus is on Series A through Series C rounds in companies that have demonstrated strong traction, achieved proof of concept, and are positioned to become future leaders in their fields.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website & curated & public directoriesWhat they invest in
from 14 of 17 portfolio companiesBiotech ×11Longevity ×7Healthtech ×6Deep Tech ×5Consumer ×2Digital Health ×2Medical Devices ×2AI & Machine Learning ×1
HQs:United States×6Switzerland×1Netherlands×1
Investments · 17 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12021 · 13 dated
Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.
BiotechDigital HealthMental HealthMountain View, US
Amit Etkin(Founder)inAdam Savitz(Executive Officer)inMichael Hanley(Executive Officer)Nicholas Smith(Chief Financial Officer and Chief Business Officer)inAaron Weaver(Director)Po Yu (Jeff) Chen(Director)
Co-investorsAble PartnersAlpha Wave GlobalInVivium CapitalK2 HealthVenturesNat TurnerValor Equity Partners+8 more
Aera Health develops a platform built on P4 medicine principles to enable personalized and proactive healthcare engagement for doctors and patients.
AI & Machine LearningDigital HealthHealthtechBasel, CH
Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools.
BiotechDeep TechLongevity
Diogo R. Feleciano(Co-Founder & CSO)inDarci J. Trader(Scientific Co-Founder / Advisor)João Ribas(Interim-CBO)in
Co-investorsApollo Health VenturesNovo Holdings
Cambrian Bio is a clinical-stage drug development company creating precision therapeutics that target metabolic pathways which decline with age, such as AMPK and mTOR.
BiotechHealthtechLongevityNew York, US
James Peyer(CEO, Founder, Board Director)inMark Nuttall(Chief Business Officer)inRuth Thieroff-Ekerdt(Chief Medical Officer)inBill DeVaul(Chief Legal Officer)in
BoardChristian Angermayer(Chairman, Co-Founder, Board Director)inMaryanna Saenko(Director)in
Co-investorsAlumni VenturesCatalio Capital Management, LPFJ LabsFuture VenturesKhosla VenturesSprint Vc+3 more
Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan.
BiotechHealthtechLongevity
Christian Angermayer(Founder)in
Co-investorsCatalio Capital Management, LPManta International Consultancy S.A.LP53 Invest
Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases.
BiotechDeep TechHealthtechLongevityMedical DevicesUtrecht, NL
Peter de Keizer(Founder and Managing Director)inTobias Madl(Head of Structural Biology, Scientific Co-founder)
Co-investorsCoastCapCurie CapitalFJ LabsApollo Health VenturesKurma PartnersROM Utrecht Region
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes.
BiotechFemTechHealthtechMedical DevicesAustin, US
Dina Turner(Co-founder & Chief Executive Officer)inMartin Varsavsky(Co-founder & Chairman)inDina Radenkovic(Founder)inMartín Varsavsky(Founder)
BoardDusan Perovic(Director)inDylan Morris(Director)in
Co-investorsBold Capital PartnersDeviation CapitalFJ LabsFuture VenturesIngeborg InvestmentsInsight Partners+18 more
BiotechSt. Petersburg, US
Christopher Shepard(Executive Officer, Director)inJarod Rutledge(Director)
BoardNils Regge(Director)in
Co-investorsApollo Health Ventures
Nula Therapeutics develops targeted small-molecule medicines that correct how the nuclear envelope regulates gene expression and cellular function.
BiotechDeep TechLongevity
Refoxy is a science-driven company focused on drug discovery, medicinal chemistry, and bioinformatics.
BiotechDeep TechHealthtechLongevity
Victor Bustos(Co-Founder & CEO)inWolfgang Link(Scientific Co-founder & Advisor)inAndrew Pierce(Chief Science Officer)in
Co-investorsApollo Health VenturesBoehringer Ingelheim Venture FundcoparionHTGF
Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease.
BiotechDeep TechLongevityBoston, US
Co-investorsApollo Health VenturesAHO Beratung Gmb HCoastCapFJ LabsAndreessen HorowitzGen.G+1 more
Storypod makes audio players and screen-free content for young children, including the Eddi all-in-one sleep, play, and learning system and Craftie/Token audio collections featuring licensed stories such as Eric Carle's "The Very Hungry Caterpillar." Its products combine sound machine and nightlight functions with expert-designed learning content aimed at early childhood development.
ConsumerEdTechHardware
Co-investorsInfinitas CapitalMiami Angels
Wonder Brands develops and sells essential household consumer products across Latin America, using an online-first omnichannel model with in-house design, sourcing, and supply chain control.
ConsumerDirect to ConsumerE-commerce
Matias Casoy(Founder)inFederico Malek(Founder)inNicolás Gonzalez Luna(Founder)in
Co-investorsBeta VenturesFlucas VenturesHi VenturesKube VCMarathon VenturesNazca+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Booster TherapeuticsCambrianSaint SassSamsara Therapeutics Inc.
Exits · 1
1 IPOsAlto NeuroscienceNYSE: ANRO
Portfolio news
latest coverage across their companiesGameto · insightpartners.com · Mar 4, 2026
Frequently asked questions
- How many investments has Korify Capital made?
- Korify Capital has 17 tracked investments, 1 of which have exited, including 2 dated in the last 24 months.
- What stage does Korify Capital invest at?
- Korify Capital invests at the Series A, Series B, Series C stages.
- What sectors does Korify Capital focus on?
- Korify Capital focuses on AI & Machine Learning, Biotech, Healthtech, Longevity, Mental Health.
- Who does Korify Capital co-invest with?
- Korify Capital most often shares deals with FJ Labs, Catalio Capital Management, LP, CoastCap, among 35 tracked co-investors.
Images
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
MPM BioImpact combines 30+ years of biotech venture capital expertise with impact investing and public market experience, managing early-stage venture funds, private/public impact funds, and a public equities fund focused on transforming patient outcomes.
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
Angelini Ventures is the venture investment arm of Angelini Industries, backing companies in healthcare and life sciences.
Equitage Ventures is an early-stage venture firm that provides capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults.